Researchers
Savić, Aleksandar
Results 21-40 of 88
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2019 | Izolovani kutani relaps primarnog limfoma centralnog nervnog sistema-prikaz slučaja![]() | Sekulić, Borivoj | Conference Paper | Mp. category will be shown later |
| 2019 | Uticaj inflamatornih parametara na ishod bolesnika sa difuznim B krupnoćelijskim nehočkinskim limfomom - rezultati jednog centra![]() | Perčić, Ivanka | Conference Paper | Mp. category will be shown later |
| 2019 | Stečeni inhibitori faktora XI koagulacije kod bolesnika sa adenokarcinomom debelog creva![]() | Dragičević Jojkić, Marina | Conference Paper | Mp. category will be shown later |
| 2019 | Poređenje prognostičkih modela (IPI, R-IPI I NCCN-IPI) kod obolelih od difuznog B-krupnoćelijskog limfoma (DBKL)![]() | Dragičević, Jojkić Marina | Conference Paper | Mp. category will be shown later |
| 2019 | Costs of sequential multiple myeloma treatment for elderly transplant-ineligible patients in the Serbian health care system | Vukićević, Đurđa; Rochau, Ursula; Rohau, Ursula; Savić, Aleksandar | Article | 51M51 |
| 2019 | Growth/differentiation factor 15, hepcidin and iron metabolism biomarkers in lymphoproliferative diseases.![]() | Agić, Danijela | Conference Paper | Mp. category will be shown later |
| 2019 | Struktura i ishod bakterijemija uzrokovanih sojem Acinetobacter spp kod hematoloških bolesnika![]() | El, Farra Amir | Conference Paper | Mp. category will be shown later |
| 2018 | Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS | De, Swart Louise; ...; Savic, Aleksandar D | Article | 22M22 |
| 2018 | Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study | Stauder, R; ...; Savic, Aleksandar D | Article | 21a+M21a+ |
| 2018 | Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes | Itzykson, Raphael; ...; Savic, Aleksandar D | Article | Mp. category will be shown later |
| 2017 | Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. a Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry | Itzykson, Raphael; ...; Savic, Aleksandar D | Conference Paper | Mp. category will be shown later |
| 2017 | Autologous stem cell transplantation for the treatment of hematological malignancies in the Clinical Center of Vojvodina![]() | Urošević, Ivana | Article | 51M51 |
| 2017 | Allogeneic hematopoietic stem cell transplantation at the Clinical Center of Vojvodina![]() | El Farra, Amir | Article | 51M51 |
| 2017 | Health-Relatedqualityof Life Is Substantially Impaired in Lower-Risk Mds When Compared with Reference Populations and Significantly Affects Overall Survival | Stauder, R; ...; Savic, Aleksandar D | Conference Paper | Mp. category will be shown later |
| 2017 | Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry | De, Swart Louise; ...; Savic, Aleksandar D | Conference Paper | Mp. category will be shown later |
| 2017 | Acute myeloid leukemia and prognosis in the era of molecular markers![]() | Sekulić, Borivoj | Article | 51M51 |
| 2016 | Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry | Langemeijer, Saskia; ...; Savic, Aleksandar D | Conference Paper | Mp. category will be shown later |
| 2016 | Comparison of 1690 Mds Patients from the European Leukemianet Registry and Reference Populations - Evidence for a Significant Impairment in QOL in Mds and Definition of Predictors of Diminished QOL | Stauder, R; ...; Savic, Aleksandar D | Conference Paper | Mp. category will be shown later |
| 2016 | Costs of Multiple Myeloma Management and Treatment for Elderly Patients Who Are Not Transplant Candidates in the Serbian Health Care System | Vukicevic, D; Rochau, Ursula; Savic, Aleksandar D | Conference Paper | Mp. category will be shown later |
| 2016 | Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trial![]() | Janic, Dragana M | Conference Paper | Mp. category will be shown later |
